Literature DB >> 22585232

Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images.

Michael E Ballard1, Gillinder Bedi, Harriet de Wit.   

Abstract

There is growing evidence that drugs of abuse alter processing of emotional information in ways that could be attractive to users. Our recent report that Δ⁹-tetrahydrocannabinol (THC) diminishes amygdalar activation in response to threat-related faces suggests that THC may modify evaluation of emotionally-salient, particularly negative or threatening, stimuli. In this study, we examined the effects of acute THC on evaluation of emotional images. Healthy volunteers received two doses of THC (7.5 and 15 mg; p.o.) and placebo across separate sessions before performing tasks assessing facial emotion recognition and emotional responses to pictures of emotional scenes. THC significantly impaired recognition of facial fear and anger, but it only marginally impaired recognition of sadness and happiness. The drug did not consistently affect ratings of emotional scenes. THC's effects on emotional evaluation were not clearly related to its mood-altering effects. These results support our previous work, and show that THC reduces perception of facial threat. Nevertheless, THC does not appear to positively bias evaluation of emotional stimuli in general.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585232      PMCID: PMC3664416          DOI: 10.1177/0269881112446530

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  62 in total

1.  Subjective and physiological effects after controlled Sativex and oral THC administration.

Authors:  E L Karschner; W D Darwin; R P McMahon; F Liu; S Wright; R S Goodwin; M A Huestis
Journal:  Clin Pharmacol Ther       Date:  2011-02-02       Impact factor: 6.875

2.  Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression.

Authors:  Jack R Cornelius; Howard J Aizenstein; Ahmad R Hariri
Journal:  Addict Behav       Date:  2010-02-10       Impact factor: 3.913

3.  Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.

Authors:  Jamie Horder; Michael Browning; Martina Di Simplicio; Philip J Cowen; Catherine J Harmer
Journal:  J Psychopharmacol       Date:  2011-03-15       Impact factor: 4.153

Review 4.  Cannabinoids and anxiety.

Authors:  Fabrício A Moreira; Carsten T Wotjak
Journal:  Curr Top Behav Neurosci       Date:  2010

5.  Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.

Authors:  Gillinder Bedi; David Hyman; Harriet de Wit
Journal:  Biol Psychiatry       Date:  2010-10-14       Impact factor: 13.382

6.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

7.  Effect of acute antidepressant administration on negative affective bias in depressed patients.

Authors:  Catherine J Harmer; Ursula O'Sullivan; Elisa Favaron; Rachel Massey-Chase; Rachael Ayres; Andrea Reinecke; Guy M Goodwin; Philip J Cowen
Journal:  Am J Psychiatry       Date:  2009-09-15       Impact factor: 18.112

8.  Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.

Authors:  Catherine J Harmer; Nicholas C Shelley; Philip J Cowen; Guy M Goodwin
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

9.  Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Authors:  Paolo Fusar-Poli; José A Crippa; Sagnik Bhattacharyya; Stefan J Borgwardt; Paul Allen; Rocio Martin-Santos; Marc Seal; Simon A Surguladze; Colin O'Carrol; Zerrin Atakan; Antonio W Zuardi; Philip K McGuire
Journal:  Arch Gen Psychiatry       Date:  2009-01

10.  Effects of endocannabinoid system modulation on cognitive and emotional behavior.

Authors:  Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar
Journal:  Front Behav Neurosci       Date:  2011-09-13       Impact factor: 3.558

View more
  19 in total

Review 1.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

2.  Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers.

Authors:  Gillinder Bedi; Laura Shiffrin; Nehal P Vadhan; Edward V Nunes; Richard W Foltin; Adam Bisaga
Journal:  J Psychopharmacol       Date:  2016-02-26       Impact factor: 4.153

3.  Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress.

Authors:  Emma Childs; Joseph A Lutz; Harriet de Wit
Journal:  Drug Alcohol Depend       Date:  2017-05-30       Impact factor: 4.492

4.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

Review 5.  Drug effects on responses to emotional facial expressions: recent findings.

Authors:  Melissa A Miller; Anya K Bershad; Harriet de Wit
Journal:  Behav Pharmacol       Date:  2015-09       Impact factor: 2.293

Review 6.  Developmental regulation of fear learning and anxiety behavior by endocannabinoids.

Authors:  T T-Y Lee; M N Hill; F S Lee
Journal:  Genes Brain Behav       Date:  2015-11-05       Impact factor: 3.449

7.  Cannabinoid Modulation of Frontolimbic Activation and Connectivity During Volitional Regulation of Negative Affect.

Authors:  Stephanie M Gorka; K Luan Phan; Maryssa Lyons; Shoko Mori; Mike Angstadt; Christine A Rabinak
Journal:  Neuropsychopharmacology       Date:  2015-12-09       Impact factor: 7.853

Review 8.  The effects of cannabis use on salience attribution: a systematic review.

Authors:  Surapi Bhairavi Wijayendran; Aisling O'Neill; Sagnik Bhattacharyya
Journal:  Acta Neuropsychiatr       Date:  2016-11-21       Impact factor: 3.403

9.  Developing a phone-based measure of impairment after acute oral ∆9-tetrahydrocannabinol.

Authors:  Elisa Pabon; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2019-08-13       Impact factor: 4.562

Review 10.  Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs.

Authors:  Josiane Bourque; Stéphane Potvin
Journal:  Front Psychiatry       Date:  2021-06-10       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.